SRSA
S.R. Schill & Associates’s iShares US Medical Devices ETF IHI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-4,512
| Closed | -$253K | – | 65 |
|
2024
Q2 | $253K | Buy |
4,512
+810
| +22% | +$45.4K | 0.11% | 71 |
|
2024
Q1 | $217K | Sell |
3,702
-78
| -2% | -$4.57K | 0.09% | 79 |
|
2023
Q4 | $204K | Buy |
+3,780
| New | +$204K | 0.09% | 82 |
|
2023
Q3 | – | Sell |
-4,807
| Closed | -$271K | – | 84 |
|
2023
Q2 | $271K | Buy |
4,807
+263
| +6% | +$14.8K | 0.12% | 67 |
|
2023
Q1 | $245K | Sell |
4,544
-565
| -11% | -$30.5K | 0.11% | 71 |
|
2022
Q4 | $269K | Sell |
5,109
-177
| -3% | -$9.31K | 0.13% | 63 |
|
2022
Q3 | $249K | Buy |
5,286
+74
| +1% | +$3.49K | 0.13% | 63 |
|
2022
Q2 | $263K | Sell |
5,212
-4,383
| -46% | -$221K | 0.13% | 57 |
|
2022
Q1 | $585K | Buy |
9,595
+200
| +2% | +$12.2K | 0.25% | 34 |
|
2021
Q4 | $619K | Buy |
9,395
+226
| +2% | +$14.9K | 0.25% | 36 |
|
2021
Q3 | $576K | Buy |
9,169
+7,631
| +496% | +$479K | 0.25% | 42 |
|
2021
Q2 | $555K | Sell |
1,538
-21
| -1% | -$7.58K | 0.22% | 48 |
|
2021
Q1 | $515K | Buy |
1,559
+154
| +11% | +$50.9K | 0.23% | 46 |
|
2020
Q4 | $460K | Buy |
1,405
+714
| +103% | +$234K | 0.21% | 48 |
|
2020
Q3 | $207K | Buy |
+691
| New | +$207K | 0.11% | 72 |
|
2020
Q1 | – | Sell |
-5,507
| Closed | -$1.46M | – | 77 |
|
2019
Q4 | $1.46M | Sell |
5,507
-1,313
| -19% | -$347K | 0.79% | 25 |
|
2019
Q3 | $1.69M | Buy |
6,820
+526
| +8% | +$130K | 0.94% | 21 |
|
2019
Q2 | $1.52M | Sell |
6,294
-9,674
| -61% | -$2.33M | 0.94% | 22 |
|
2019
Q1 | $3.7M | Buy |
15,968
+3,549
| +29% | +$822K | 2.23% | 11 |
|
2018
Q4 | $2.48M | Buy |
12,419
+421
| +4% | +$84.1K | 1.74% | 13 |
|
2018
Q3 | $2.73M | Buy |
+11,998
| New | +$2.73M | 1.68% | 16 |
|